Clinical Trial Update: Lapatinib and RAD-001 for HER2 Positive Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial update evaluating the combination of lapatinib and RAD-001 (everolimus) for HER2-positive metastatic breast cancer. The current status of the tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Everolimus (everolimus)
• Lapatinib (Lapatinib)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Metastatic Breast Cancer | Phase 2 | Status: UNKNOWN